retatrutide trial news Great again!!! A phase 2 of (Triple–Hormone-Receptor Agonist) for obesity. At 48 wks the median body weight loss was 24.2% and >5%, >10% and >15% had occurred in 100% Retatrutide Achieves Large Weight Decreases

doi: 10.3390/molecules25143152 [DOI] [PMC free article] [PubMed] [Google Scholar] 156.Aakre I, Solli DD, Markhus MW, Mhre HK, Dahl L, Henjum S, et al

GCGR agonism: Acts on glucagon receptors, promotes fat decomposition, accelerates energy consumption, and at a specific dose can regulate liver glycogen metabolism to avoid the risk of hypoglycemia

(2003) Urinary and plasma homocysteine and cysteine levels during prolonged oral N-acetylcysteine therapy

small human trials with topical T4 suggested accelerated wound healing

Even an extra 30 to 60 minutes of consolidated sleep can measurably improve cortisol regulation, hunger hormone balance, and insulin sensitivity